Dose-response and Therapeutic Time-window of Compound 21: a Randomized Preclinical Trial in Rat Model of Thromboembolic Stroke

被引：0
|
作者：
Ishrat, Tauheed
Fouda, Abdelrahman Y.
Pillai, Bindu
Eldahshan, Wael
Ahmed, Heba
Waller, Jennifer L.
Ergul, Adviye
Fagan, Susan C.
机构：
[1] Univ Georgia, Augusta, GA USA
[2] Georgia Regents Univ, Augusta, GA USA
来源：
STROKE | 2016年 / 47卷
关键词：
Compound C21; angiotensin type II receptor agonist; embolic middle cerebral artery occlusion; functional outcome; ischemic stroke; Stroke recovery; Angiotensin II; Neuroprotection; Infarct size;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WP113
引用
收藏
页数：3
相关论文
共 34 条
  • [1] Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke
    Ishrat, Tauheed
    Fouda, Abdelrahman Y.
    Pillai, Bindu
    Eldahshan, Wael
    Ahmed, Heba
    Waller, Jennifer L.
    Ergul, Adviye
    Fagan, Susan C.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 (08): : 1635 - 1647
  • [2] Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study
    Wali, Bushra
    Ishrat, Tauheed
    Won, Soonmi
    Stein, Donald G.
    Sayeed, Iqbal
    BRAIN, 2014, 137 : 486 - 502
  • [3] Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat
    Dohare, Preeti
    Garg, Puja
    Jain, Vikas
    Nath, Chandishwar
    Ray, Madhur
    BEHAVIOURAL BRAIN RESEARCH, 2008, 193 (02) : 289 - 297
  • [4] Neuroprotective properties of catalpol in transient global cerebral ischemia in gerbils: dose-response, therapeutic time-window and long-term efficacy
    Li, DQ
    Bao, YM
    Zhao, JJ
    Liu, CP
    Liu, Y
    An, LJ
    BRAIN RESEARCH, 2004, 1029 (02) : 179 - 185
  • [5] A randomized dose-response trial of citicoline in acute ischemic stroke patients
    Clark, WM
    Warach, SJ
    Pettigrew, LC
    Gammans, RE
    Sabounjian, LA
    NEUROLOGY, 1997, 49 (03) : 671 - 678
  • [6] THE DOSE-RESPONSE RELATIONSHIP AND THERAPEUTIC WINDOW FOR DIZOCILPINE (MK-801) IN A RAT FOCAL ISCHEMIA MODEL
    HATFIELD, RH
    GILL, R
    BRAZELL, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 216 (01) : 1 - 7
  • [7] Neuroprotective efficacy of GLI 5021 in in vitro and in vivo stroke models:: Dose-response and therapeutic window
    del Balzo, U
    Wang, B
    Brown, LA
    Cao, W
    Khansari, PS
    Park, LC
    Flaim, SF
    STROKE, 2002, 33 (01) : 402 - 402
  • [8] Improvement in mitochondrial dysfunction as a new surrogate efficiency measure for preclinical trials: dose-response and time-window profiles for administration of the calcium channel blocker Ziconotide in experimental brain injury
    Verweij, BH
    Muizelaar, JP
    Vinas, FC
    Peterson, PL
    Xiong, Y
    Lee, CP
    JOURNAL OF NEUROSURGERY, 2000, 93 (05) : 829 - 834
  • [9] Synergistic neuroprotection by a PAF antagonist plus a docosanoid in experimental ischemic stroke: Dose-response and therapeutic window
    Reid, Madigan M.
    Obenaus, Andre
    Mukherjee, Pranab K.
    Khoutorova, Larissa
    Roque, Cassia R.
    Petasis, Nicos A.
    Oria, Reinaldo B.
    Belayev, Ludmila
    Bazan, Nicolas G.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (08):
  • [10] THERAPEUTIC TIME WINDOW AND DOSE-RESPONSE OF THE BENEFICIAL-EFFECTS OF KETAMINE IN EXPERIMENTAL HEAD-INJURY
    SHAPIRA, Y
    LAM, AM
    ENG, CC
    LAOHAPRASIT, V
    MICHEL, M
    STROKE, 1994, 25 (08) : 1637 - 1643
1234